Dale Brumfield's Back Page piece on Avastin (“Obama's Drug War,” Jan. 19) shows a strong political bias; after doing some research you will see a different perspective. Business Week's article on the subject stated: “Avastin was approved for breast cancer in February 2008 based on preliminary evidence suggesting it slowed disease progression. Two follow-up trials showed Avastin didn't prolong survival in women with breast cancer or improve symptoms, and the drug had a smaller effect on tumor growth than the Food and Drug Administration had expected. The agency decided the benefits didn't outweigh potential risks of serious bleeding, heart attacks and kidney damage.” I believe the FDA is supposed to determine the safety of food and drugs, so it appears it is just doing its job. Kathy Kurtz Henrico
Style Weekly's mission is to provide smart, witty and tenacious coverage of Richmond. Our editorial team strives to reveal Richmond's true identity through unflinching journalism, incisive writing, thoughtful criticism, arresting photography and sophisticated presentation.
We make sense of the news; pursue those in power; explore the city's arts and culture; open windows on provocative ideas; and help readers know Richmond through its people. We give readers the information to make intelligent decisions.